Enzo Biochem, Inc. (ENZ) has an overall financial health rating of C with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2025-04-17.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-04-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-04-16 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-04-15 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-04-14 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-04-11 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-04-10 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-04-09 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-04-08 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-04-07 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-04-04 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-04-03 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-04-02 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
